News

He earlier served as the president and chief executive officer (CEO) of Jostens, Inc., from 1994 to 2004 and as chairman from 1998 to 2004. Before joining Jostens,

The terms of the agreement includes an upfront payment, regulatory milestones and sales milestones. The total value of the upfront payment and milestones are $4.75 million. In addition,

The agreement calls for Medimetriks to receive a percentage of Perrigo’s net sales on the non-branded products, allowing Medimetriks to maximize its investment in its brands and maintain

In the study, an HIV-infected individual completed a 12 treatment study of the Aethlon Hemopurifier administered thrice weekly over the course of 30-days. The study was conducted at

Consolidated operating income was JPY42.6 billion (up 31.8%), recurring income was JPY43.2 billion (up 32.1%), and net income was JPY10.4 billion (down 56.5%). Net income was affected by

The project utilizes a proprietary antigen design technology developed by Algonomics and will be funded by IAVI’s Innovation Fund, a funding mechanism that seeks out novel and typically

Prior to the Dow appointment, she served as director of Research and Development for Biocor Animal Health (Biocor) where she was responsible for all aspects of design and

To conserve capital resources, Altus will discontinue its Trizytek program activities and focus on the advancement of the company’s breakthrough, long-acting, recombinant human growth hormone candidate, ALTU-238, as

The license expands Artemis’s clinical and research program and will allow the company to develop a non-invasive prenatal blood test that accurately predicts chromosomal and genetic disorders. This